SCHEMBL6414145

SCHEMBL6414145

ClCCOc1cc(-c2cccs2)n[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.48
POLB P06746 2/20 0.41
LMNA P02545 1/20 0.41
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
ADORA3 P0DMS8 1/20 0.38
KMT2A Q03164 7/20 0.38
MEN1 O00255 6/20 0.38
KDM4E B2RXH2 5/20 0.38
MAPT P10636 4/20 0.38
HPGD P15428 4/20 0.38
ALDH1A1 P00352 4/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
RAB9A P51151 4/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6420160 0.79 SMN1; SMN2 (0.61) SMN1; SMN2LMNADRD2DRD4DRD3
SCHEMBL6414035 0.68 SMN1; SMN2 (0.58) SMN1; SMN2POLBLMNAADORA3KMT2A
SCHEMBL1143192 0.68 SMN1; SMN2 (0.58) SMN1; SMN2POLBLMNADRD2DRD4
SCHEMBL6412005 0.68 SMN1; SMN2 (0.58) SMN1; SMN2POLBLMNADRD2DRD4
SCHEMBL624712 0.68 SMN1; SMN2 (0.54) SMN1; SMN2POLBLMNADRD2DRD4
SCHEMBL14400727 0.68 SMN1; SMN2 (0.54) SMN1; SMN2POLBLMNADRD2DRD4
SCHEMBL4923288 0.66 SMN1; SMN2 (0.55) SMN1; SMN2POLBDRD2DRD4DRD3
SCHEMBL28779334 0.66 SMN1; SMN2 (0.45) SMN1; SMN2POLBLMNADRD2DRD4
SCHEMBL5207573 0.65 SMN1; SMN2 (1.00) SMN1; SMN2LMNAADORA3KMT2AMEN1
SCHEMBL14373074 0.65 SMN1; SMN2 (0.54) SMN1; SMN2POLBLMNAADORA3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050048092-A1 Thienyl-pyrazoles and their use for controlling pests WADA KATSUAKI (JP) 2005-03-03 US disclosed
US-6593358-B1 Method for controlling pests, comprising the step of allowing a pesticidally effective amount of one or more compounds selected from the group consisting of one or more compounds of the formula (Ia) according to claim 2 and one or compounds NIHON BAYER AGROCHEM K.K. (JP) 2003-07-15 US disclosed
EP-1200425-A1 THIENYL-PYRAZOLES AND THEIR USE FOR CONTROLLING PESTS NIHON BAYER AGROCHEM K.K. (JP) 2002-05-02 EP disclosed
WO-2001005787-A1 THIENYL-PYRAZOLES AND THEIR USE FOR CONTROLLING PESTS NIHON BAYER AGROCHEM K.K. (DE) 2001-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050048092-A1 Thienyl-pyrazoles and their use for controlling pests CBR3, C1S, CYP4B1 SMN1; SMN2 4328/4885POLB 4567/4885LMNA 4090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.